“TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLP-1 RECEPTOR AGONISTS, CHRONIC KIDNEY DISEASE AND INFLUENCE ON CARDIOVASCULAR RISK” (2025) TRAKIA JOURNAL OF SCIENCES, 23(Supplement 1), p. 6. doi:10.15547/tjs.2025.s.01.004.